Cargando…
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
PURPOSES: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Recent researches have demonstrated that m6A methylation regulators play a key role in various cancers, such as gastric cancer and colon adenocarcinoma. Several m6A methylation regulators are reported t...
Autores principales: | Wu, Xiaomin, Zhang, Xiaojing, Tao, Leilei, Dai, Xichao, Chen, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378627/ https://www.ncbi.nlm.nih.gov/pubmed/32733931 http://dx.doi.org/10.1155/2020/2053902 |
Ejemplares similares
-
Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020) -
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
por: Chang, Xian, et al.
Publicado: (2021) -
Gene Signatures and Prognostic Values of m6A RNA Methylation
Regulators in Ovarian Cancer
por: Han, Xiao, et al.
Publicado: (2020) -
Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022) -
Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)